Featured In

Bordoloi Biotech

Bordoloi Biotech was founded in 2012 with the mission of developing focused chemistry solutions of unmet needs in biological systems targeted in the areas of inflammation and pain, and tissue engineering and hemostasis.

FOCUS
AREAS

Over the past seven years Bordoloi Biotech (BB) has matured to a leading organization in developing technology solutions for unmet needs with granted US patents. BB has licensed patent for commercial development, as well as seeking opportunities to license. Bordoloi Biotech specializes in the research and development of chemistry solutions of unmet needs in the following areas

LEARN MORE

  • CONTROLLING
    FIBRIN LONGEVITY
  • ANTI-INFLAMMATORY
    HERBAL PRODUCTS

LATEST
NEWS

In our researches, we strive to deliver the ideas revolving around chemistry solutions in a biological system with the best possible ways. Following are our most recent distributed contextual analysis in our particular field of study.

KNOW MORE